Related Experiment Video

Updated: Dec 21, 2025

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

528

Co-treatment of lower urinary tract symptoms and cardiovascular disease - where do we stand?

Karolina Semczuk-Kaczmarek1, Anna E Płatek2, Filip M Szymański1

  • 11 Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Central European Journal of Urology
|May 13, 2020
PubMed

Insights

Treating cardiovascular risk factors may improve lower urinary tract symptoms (LUTS). Lifestyle changes and medications for cardiovascular disease (CVD) can reduce LUTS severity and cardiovascular mortality.

Area of Science:

  • Urology
  • Cardiology
  • Preventive Medicine

Background:

  • The link between cardiovascular disease (CVD) and lower urinary tract symptoms (LUTS) is recognized.
  • Healthy lifestyle choices, including diet and exercise, are crucial for managing LUTS severity.

Purpose of the Study:

  • To explore the association between LUTS and cardiovascular risk.
  • To discuss potential clinical implications for patient management.

Main Methods:

  • A comprehensive literature search was conducted.
  • The search focused on studies examining the relationship between LUTS and cardiovascular risk factors.

Main Results:

  • Cardiovascular risk reduction therapies may alleviate LUTS.
  • Statins show potential in reducing benign prostatic hyperplasia (BPH) risk and slowing LUTS progression in hyperlipidemic patients.
  • Angiotensin II receptor blockers may decrease LUTS severity in hypertensive individuals.

Conclusions:

  • A holistic approach involving urologists and cardiologists is essential for early CVD diagnosis and treatment in LUTS patients.
  • Treatments targeting cardiovascular health, such as antihypertensives, antithrombotics, and hypolipidemic therapies, alongside healthy lifestyles, can reduce both cardiovascular mortality and LUTS severity.
Abstract

Keywords:
adjuvantcardiovascular diseasecardiovascular risklower urinary tract symptoms

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
154
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
807
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
472
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
175
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
139